Bolt Biotherapeutics Inc
NASDAQ:BOLT
Cash Flow Statement
Cash Flow Statement
Bolt Biotherapeutics Inc
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(39)
|
(36)
|
(39)
|
(61)
|
(77)
|
(89)
|
(102)
|
(99)
|
(98)
|
(97)
|
(95)
|
(88)
|
(81)
|
(77)
|
(71)
|
(69)
|
(63)
|
(66)
|
(65)
|
(63)
|
(63)
|
(51)
|
(43)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
3
|
5
|
7
|
9
|
9
|
10
|
10
|
10
|
9
|
7
|
4
|
9
|
4
|
7
|
8
|
7
|
6
|
4
|
3
|
|
| Other Non-Cash Items |
2
|
2
|
0
|
15
|
23
|
26
|
32
|
20
|
15
|
15
|
14
|
13
|
11
|
9
|
8
|
8
|
7
|
8
|
8
|
8
|
7
|
6
|
5
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
(3)
|
(3)
|
(2)
|
(2)
|
16
|
18
|
21
|
16
|
(1)
|
3
|
(3)
|
(7)
|
(4)
|
(12)
|
(10)
|
(9)
|
(8)
|
(6)
|
(8)
|
(4)
|
(8)
|
(11)
|
|
| Cash from Operating Activities |
(36)
N/A
|
(36)
-1%
|
(41)
-12%
|
(47)
-16%
|
(54)
-15%
|
(46)
+15%
|
(52)
-13%
|
(57)
-9%
|
(65)
-14%
|
(82)
-26%
|
(76)
+6%
|
(77)
0%
|
(76)
+1%
|
(70)
+8%
|
(73)
-5%
|
(70)
+5%
|
(63)
+10%
|
(64)
-2%
|
(61)
+4%
|
(61)
0%
|
(58)
+6%
|
(51)
+11%
|
(47)
+8%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Other Items |
(13)
|
(8)
|
(20)
|
(17)
|
(195)
|
(246)
|
(249)
|
(230)
|
2
|
48
|
65
|
60
|
47
|
61
|
72
|
71
|
52
|
57
|
61
|
58
|
62
|
55
|
56
|
|
| Cash from Investing Activities |
(14)
N/A
|
(10)
+33%
|
(22)
-135%
|
(21)
+8%
|
(198)
-859%
|
(249)
-26%
|
(252)
-1%
|
(232)
+8%
|
(1)
+100%
|
45
N/A
|
62
+39%
|
58
-7%
|
46
-20%
|
60
+31%
|
72
+19%
|
71
-1%
|
52
-26%
|
57
+8%
|
61
+8%
|
58
-6%
|
62
+8%
|
55
-12%
|
55
+1%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
297
|
311
|
311
|
311
|
14
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
64
|
40
|
39
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
49
N/A
|
64
+32%
|
41
-36%
|
40
-3%
|
337
+750%
|
308
-8%
|
310
+0%
|
311
+1%
|
14
-95%
|
1
-93%
|
1
-17%
|
1
-42%
|
0
-22%
|
0
-26%
|
0
N/A
|
0
-13%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
-41%
|
0
N/A
|
0
-60%
|
0
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||
| Net Change in Cash |
(1)
N/A
|
18
N/A
|
(22)
N/A
|
(28)
-27%
|
85
N/A
|
14
-84%
|
6
-58%
|
22
+272%
|
(51)
N/A
|
(36)
+31%
|
(13)
+63%
|
(18)
-39%
|
(29)
-61%
|
(9)
+69%
|
(1)
+86%
|
2
N/A
|
(10)
N/A
|
(7)
+32%
|
0
N/A
|
(4)
N/A
|
4
N/A
|
3
-18%
|
8
+147%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(37)
N/A
|
(38)
-3%
|
(43)
-14%
|
(51)
-17%
|
(57)
-13%
|
(49)
+15%
|
(55)
-12%
|
(59)
-8%
|
(68)
-14%
|
(84)
-24%
|
(79)
+7%
|
(78)
+0%
|
(77)
+2%
|
(71)
+8%
|
(74)
-4%
|
(70)
+5%
|
(63)
+10%
|
(64)
-2%
|
(61)
+5%
|
(61)
0%
|
(58)
+6%
|
(51)
+11%
|
(47)
+8%
|
|